Health adolescents COVID-19, booster, vaccine
Conditions
Interventions
This arm is a group of adolescent Thai individuals who received 2 doses of BNT162b2 vaccines. They were enrolled to recieve a booster dose (third dose vaccine) which is Pfizer (PF) full dose after 3
Active Comparator Biological/Vaccine,Active Comparator Biological/Vaccine,Experimental Biological/Vaccine
Booster with PZ in two-dose PZ recipient,Booster with PZ in two-dose SP recipient,Booster with Covovax in two-dose SP or BNT162b2 recipient
Sponsors
Chulalongkorn University
Eligibility
Sex/Gender
All
Age
12 Years to 18 Years
Inclusion criteria
Inclusion criteria: 1. Healthy adolecents (aged between 12-18 years) who have previously received two doses following the ministry of public health (official proof of vaccinations required). 2. Have received your second dose of COVID-19 vaccine more than 3 months. 3. Have or Have not previously had COVID-19 infection. 4. are not in immunocompromised states (chronic diseases or immunodeficiency disorder) 5. No oallergies to the vaccine components 6. Are available for follow-ups and blood draws
Exclusion criteria
Exclusion criteria: 1. Immunodeficiency status 2. Do not agree to participate 3. Severe coagulopathy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| immunogenicity 1 month neutralizing antibody against BA.5 | — |
Secondary
| Measure | Time frame |
|---|---|
| safety 1 month Frequency of adverse events | — |
Countries
Thailand
Contacts
Public ContactNasamon Wanlapakorn
Faculty of Medicine, Chulalongkorn University
Outcome results
None listed